Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Record identifier

TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_233268527

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_233268527

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Full title

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial

Publisher

England: BMJ Publishing Group LTD

Journal title

BMJ (Online), 2020, Vol.371, p.m4328

Record Identifier

TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_233268527

Language

Formats

Publication information

Publisher

Subjects

Subjects and topics

2-year efficacy Abatacept - therapeutic use Adult Aged american-college Anti-Citrullinated Protein Antibodies - immunology Antibodies, Monoclonal, Humanized - therapeutic use Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - immunology Basic Medicine Biological products Biological Products - therapeutic use C-reactive protein C-Reactive Protein - immunology Certolizumab Pegol - therapeutic use Citrulline Clinical Medicine combination Confidence intervals Corticosteroids Cytokines Denmark Disease Drug dosages Drug Therapy, Combination Early Medical Intervention Female Finland General & Internal Medicine Geriatrics Geriatrik Glucocorticoids - therapeutic use Humans Hydroxychloroquine Hydroxychloroquine - therapeutic use Hypotheses Immunologi inom det medicinska området Immunology in the medical area Injections, Intra-Articular Joint diseases Klinisk medicin Male Medical and Health Sciences Medical treatment Medicin och hälsovetenskap Medicinska och farmaceutiska grundvetenskaper Methotrexate Methotrexate - therapeutic use methotrexate monotherapy Middle Aged Monoclonal antibodies multicenter Netherlands non-inferiority Norway parallel-group Patients plus methotrexate Population Prednisolone Prednisolone - therapeutic use Proteins Remission Reumatologi och inflammation Rheumatoid arthritis Rheumatoid factor Rheumatoid Factor - immunology Rheumatology Rheumatology and Autoimmunity rheumatology/european league Severity of Illness Index Single-Blind Method Standard deviation Statistical analysis Sulfasalazine Sulfasalazine - therapeutic use Sweden Treatment Outcome Tumor necrosis factor-TNF Tumor necrosis factor-α

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_233268527

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_prod_swepub_kib_ki_se_233268527

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI